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Carbapenem-resistant *Enterobacteriaceae* (CRE), such as *Klebsiella pneumoniae*, are classified as critical on the World Health Organization's list of priority pathogens ([@B1]). Resistance to carbapenems, the traditional last-resort treatment option for severe community- and hospital-acquired infections, has been reported at proportions up to 54% ([@B2]). While CRE remain rare in Scandinavia, their arrival and subsequent local expansion from high-prevalence locations, such as through the return of patients hospitalized overseas, is a concern ([@B3], [@B4]). In 2010, the carbapenem-resistant strain *Klebsiella pneumoniae* K66-45, belonging to sequence type 11 (part of CG258), was isolated and cultured from a catheter urine sample following the return of a Norwegian patient previously hospitalized in India ([@B5]). Antimicrobial susceptibility testing and PCR analysis revealed resistance to a wide range of antibiotics, including meropenem and ertapenem, and the presence (but not location) of *bla*~NDM-1~, which encodes the New Delhi metallo-β-lactamase-1 (NDM-1), as well as genes encoding several other β-lactamases ([@B5]). To facilitate further investigation into the genetic basis of CRE and the dissemination of carbapenemases among Gram-negative bacteria, the genome sequence of *K. pneumoniae* K66-45 was determined using next-generation sequencing technology.

Genomic DNA was prepared from an overnight culture of *K. pneumoniae* K66-45 using the MO BIO DNeasy UltraClean Microbial kit (Qiagen, USA). The DNA libraries for single-molecule real-time (SMRT) sequencing were constructed using the BluePippin preparative electrophoresis system (Sage Science, USA) with a 9-kb cutoff. Sequencing was performed using one SMRT cell of the Pacific Biosciences RS II instrument, using P6-C4 chemistry with a 360-min movie time. A total of 104,622 reads were assembled using HGAPv3 (SMRT Analysis version 2.3.0, Pacific Biosciences, USA). Artifact frameshifts in the PacBio sequence were corrected using Pilon ([@B6]), and Bowtie2 ([@B7]) was subsequently used to map 99.4% of available Illumina sequence reads (\>300× coverage, GenBank accession no. NZ_LNGZ01000000) back to the Pilon-corrected PacBio consensus sequence. Annotation was performed with the NCBI Prokaryotic Genome Annotation Pipeline.

The *K. pneumoniae* K66-45 genome contains a single \~5.4-Mb chromosome, encoding the SHV-11 β-lactamase, and four plasmids, pK66-45-1 to pK66-45-4, which encode the multidrug resistance basis of the strain. The plasmid-based resistance determinants include *bla*~NDM-1~, *bla*~CTX-M-15~, *armA*, *aadA2*,*qnrS*, *dfrA12*, and *sul1* identified on pK66-45-1 (338,512 bp); *bla*~OXA-1~, *aac(6′)*-*Ib-cr*, and *aph(3′)-Ia* on pK66-45-2 (200,356 bp); and *bla*~OXA-1~, *bla*~CTX-M-15~, *bla*~OXA-9~, *bla*~TEM-1A~, *aac(6′)-Ib-cr*,*aac(6′)-Ib*, and*aadA1* on pK66-45-3 (120,533 bp). No resistance determinants were identified on pK66-45-4 (41,111 bp). As shown previously, the bleomycin resistance gene *ble*~MBL~ was located downstream of *bla*~NDM-1~ ([@B8]). This repertoire of genes illustrates the immense reservoir of resistance determinants associated with mobile genetic elements such as plasmids. The acquisition of these plasmids by pathogens such as *K. pneumoniae* is a major driver in the increase in multidrug resistance that now threatens modern medicine.

As CRE isolates remain rare in Scandinavia, this complete genome sequence will provide a valuable reference for investigations into the dissemination and evolution of multidrug resistance, as well as for improved infection control measures for CRE.
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